352 related articles for article (PubMed ID: 15226358)
1. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response.
Saccani S; Marazzi I; Beg AA; Natoli G
J Exp Med; 2004 Jul; 200(1):107-13. PubMed ID: 15226358
[TBL] [Abstract][Full Text] [Related]
2. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation.
Lenert P; Stunz L; YI AK; Krieg AM; Ashman RF
Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):247-56. PubMed ID: 11572601
[TBL] [Abstract][Full Text] [Related]
3. Nuclear ubiquitin ligases, NF-kappaB degradation, and the control of inflammation.
Natoli G; Chiocca S
Sci Signal; 2008 Jan; 1(1):pe1. PubMed ID: 18270169
[TBL] [Abstract][Full Text] [Related]
4. The early response gene IEX-1 attenuates NF-kappaB activation in 293 cells, a possible counter-regulatory process leading to enhanced cell death.
Arlt A; Kruse ML; Breitenbroich M; Gehrz A; Koc B; Minkenberg J; Fölsch UR; Schäfer H
Oncogene; 2003 May; 22(21):3343-51. PubMed ID: 12761504
[TBL] [Abstract][Full Text] [Related]
5. A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells.
Shumway SD; Miyamoto S
Biochem J; 2004 May; 380(Pt 1):173-80. PubMed ID: 14763901
[TBL] [Abstract][Full Text] [Related]
6. Recruitment of IkappaBalpha to the hes1 promoter is associated with transcriptional repression.
Aguilera C; Hoya-Arias R; Haegeman G; Espinosa L; Bigas A
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16537-42. PubMed ID: 15536134
[TBL] [Abstract][Full Text] [Related]
7. IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy.
Tergaonkar V; Bottero V; Ikawa M; Li Q; Verma IM
Mol Cell Biol; 2003 Nov; 23(22):8070-83. PubMed ID: 14585967
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway.
Sasaki CY; Barberi TJ; Ghosh P; Longo DL
J Biol Chem; 2005 Oct; 280(41):34538-47. PubMed ID: 16105840
[TBL] [Abstract][Full Text] [Related]
9. Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms.
Li N; Karin M
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13012-7. PubMed ID: 9789032
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nuclear factor-kappaB activation induces apoptosis in cerebellar granule cells.
Piccioli P; Porcile C; Stanzione S; Bisaglia M; Bajetto A; Bonavia R; Florio T; Schettini G
J Neurosci Res; 2001 Dec; 66(6):1064-73. PubMed ID: 11746438
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation.
Han Y; Weinman S; Boldogh I; Walker RK; Brasier AR
J Biol Chem; 1999 Jan; 274(2):787-94. PubMed ID: 9873017
[TBL] [Abstract][Full Text] [Related]
12. Enhanced proteolysis of IkappaBalpha and IkappaBbeta proteins in astrocytes by Moloney murine leukemia virus (MoMuLV)-ts1 infection: a potential mechanism of NF-kappaB activation.
Kim HT; Qiang W; Wong PK; Stoica G
J Neurovirol; 2001 Oct; 7(5):466-75. PubMed ID: 11582519
[TBL] [Abstract][Full Text] [Related]
13. Deletion of IκBα activates RelA to reduce acute pancreatitis in mice through up-regulation of Spi2A.
Neuhöfer P; Liang S; Einwächter H; Schwerdtfeger C; Wartmann T; Treiber M; Zhang H; Schulz HU; Dlubatz K; Lesina M; Diakopoulos KN; Wörmann S; Halangk W; Witt H; Schmid RM; Algül H
Gastroenterology; 2013 Jan; 144(1):192-201. PubMed ID: 23041330
[TBL] [Abstract][Full Text] [Related]
14. An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IkappaBalpha.
Johnson C; Van Antwerp D; Hope TJ
EMBO J; 1999 Dec; 18(23):6682-93. PubMed ID: 10581242
[TBL] [Abstract][Full Text] [Related]
15. The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents.
Ma MH; Yang HH; Parker K; Manyak S; Friedman JM; Altamirano C; Wu ZQ; Borad MJ; Frantzen M; Roussos E; Neeser J; Mikail A; Adams J; Sjak-Shie N; Vescio RA; Berenson JR
Clin Cancer Res; 2003 Mar; 9(3):1136-44. PubMed ID: 12631619
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors.
Sakai T; Kambe F; Mitsuyama H; Ishiguro N; Kurokouchi K; Takigawa M; Iwata H; Seo H
J Bone Miner Res; 2001 Jul; 16(7):1272-80. PubMed ID: 11450703
[TBL] [Abstract][Full Text] [Related]
17. BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function.
Morrison TE; Kenney SC
Virology; 2004 Oct; 328(2):219-32. PubMed ID: 15464842
[TBL] [Abstract][Full Text] [Related]
18. p28(GANK) associates with p300 to attenuate the acetylation of RelA.
Ren YB; Luo T; Li J; Fu J; Wang Q; Cao GW; Chen Y; Wang HY
Mol Carcinog; 2015 Dec; 54(12):1626-35. PubMed ID: 25400040
[TBL] [Abstract][Full Text] [Related]
19. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer.
Wong BC; Jiang Xh; Fan XM; Lin MC; Jiang SH; Lam SK; Kung HF
Oncogene; 2003 Feb; 22(8):1189-97. PubMed ID: 12606945
[TBL] [Abstract][Full Text] [Related]
20. Activation of NF-kappa B/Rel by Tax involves degradation of I kappa B alpha and is blocked by a proteasome inhibitor.
Maggirwar SB; Harhaj E; Sun SC
Oncogene; 1995 Sep; 11(5):993-8. PubMed ID: 7675460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]